114 related articles for article (PubMed ID: 1958488)
1. Familial clustering of defective release of t-PA.
Petäjä J; Rasi V; Vahtera E; Myllylä G
Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic response to venous occlusion for 10 and 20 minutes in healthy subjects and in patients with deep vein thrombosis.
Petäjä J
Thromb Res; 1989 Oct; 56(2):251-63. PubMed ID: 2515609
[TBL] [Abstract][Full Text] [Related]
3. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
[TBL] [Abstract][Full Text] [Related]
4. Familial hypofibrinolysis and venous thrombosis.
Petäjä J; Rasi V; Myllylä G; Vahtera E; Hallman H
Br J Haematol; 1989 Mar; 71(3):393-8. PubMed ID: 2495018
[TBL] [Abstract][Full Text] [Related]
5. Venous thrombosis and tissue plasminogen activator release deficiency: a family study.
Patrassi GM; Sartori MT; Viero ML; Boscaro M; Boeri G; Girolami A
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):231-5. PubMed ID: 1909902
[TBL] [Abstract][Full Text] [Related]
6. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
Falkon L; Garí M; Borrell M; Fontcuberta J
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
[TBL] [Abstract][Full Text] [Related]
7. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
[TBL] [Abstract][Full Text] [Related]
8. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
Jørgensen M; Bonnevie-Nielsen V
Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
[TBL] [Abstract][Full Text] [Related]
9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
10. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion.
Cugno M; Uziel L; Fabrizi I; Bottasso B; Maggiolini F; Agostoni A
Thromb Res; 1989 Dec; 56(5):625-34. PubMed ID: 2516662
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
[TBL] [Abstract][Full Text] [Related]
13. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
[TBL] [Abstract][Full Text] [Related]
14. Altered fibrinolysis in DVT: influence of site of sampling.
Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
Hach-Wunderle V; Scharrer I
Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122
[TBL] [Abstract][Full Text] [Related]
16. Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis.
Stegnar M; Peternel P; Keber D; Vene N
Thromb Res; 1991 Nov; 64(4):445-53. PubMed ID: 1788830
[TBL] [Abstract][Full Text] [Related]
17. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
19. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
20. Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levels.
Alessi MC; Juhan-Vague I; Declerck PJ; Anfosso F; Gueunoun E; Collen D
Thromb Res; 1990 Dec; 60(6):509-16. PubMed ID: 2127964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
